WASHINGTON — At a House oversight hearing Thursday, the Biden administration’s top drug policy official emphasized the need to address both mental illness and drug addiction simultaneously to reduce fentanyl deaths.
According to a 2021 survey by the Substance Abuse and Mental Health Services Administration, over nine million adults in the U.S. have this co-occuring disorder.
“We’re talking about people who lack the resources they need to treat mental illness, who face stigma in obtaining treatment, and who may self-medicate with alcohol, fentanyl,” said the committee’s ranking member Jamie Raskin (D-Md.) in his opening statement. He called on Congress to address the prevalence of untreated mental illness fueling the illicit drug market.
About the Author Reprints
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.